Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Futamura is a global leader in the manufacturing of sustainable cellulose films and activated carbon, serving critical roles in the pharmaceutical and healthcare industries. The company provides specialized packaging solutions, including compostable films for medical devices and pharmaceutical products, ensuring safety and shelf-life stability. Its activated carbon division produces high-purity materials used in the purification of active pharmaceutical ingredients (APIs) and the treatment of medical-grade water. Following the 2016 acquisition of Innovia Films' cellulose business, Futamura became the world's largest producer of cellulose-based films. The company operates major manufacturing facilities in Japan, the United Kingdom, and the United States, focusing on bio-based materials and environmental sustainability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Futamura Group.